Appreciate the feedback. Gotta get with the lab and make sure I dont screw it up this time.
Very Nice of
@janoshik to find a lab for us and it ain't like this gets done every day in the UG. Usually takes a few attempts to smooth out the kinks.
This is your show man, but you may find this useful. In discussion with the guys that handled the Tirz NMR analysis, they offered CD as an option for rHGH that would capture defects they thought likely in UGL rHGH, but be cost effective enough for routine analysis. (unlike NMR)
Both of these conditions still appear "pure" under HPLC-MS.
1. rhGH is relatively “sticky” once partially unfolded. Many forms of stress induce this partial unfolding (IE less than ideal storage conditions like uncontrolled temps in transport, and the haphazard formulations common in UGL). It can still be bioactive in this condition. Once partially unfolded it's susceptible to self‐associating into inactive aggregates. This can happen seconds after reconstitution (likely the cause of "cloudiness") or over days or weeks.
For partial unfolding they'll need to look for "A reduction in the characteristic 208/222 nm negative minima (loss of α‐helix signal) and/or the appearance of a β‐sheet–like shoulder around ~216 nm."
So this is a measure of quality that predicts how quickly the rHGH will degrade. Monitoring by far-UV CD (for α-helix loss) is a sensitive way to catch it early.
--------
2. Although well manufactured rhGH is stable, there's plenty of room for sloppiness in UGL rHGH manufacturing via slight deviations such as transient pH shifts during dialysis, small amounts of organic solvent carryover, or buffer ionic‐strength change which can damage the hydrogen‐bond network in its core helices. Instead of completely aggregating, many molecules simply lose one or two helices and adopt a molten-globule–like state.
For this, they'll need to look for "A shallower double minimum at 208 nm and 222 nm compared to a “textbook” rhGH spectrum. If only a fraction of molecules misfold, you see a blend (native + unfolded) and can estimate the percentage of misfolded species."
This will find inactive rHGH that hasn't aggregated but's inactive despite appearing pure on HPLC-MS. The next best thing to an bioactivity assay.
We couldn't do this because it's a US based lab and in the end there was no legal workaround that would allow them to accept a rHGH sample from us.
Will be great to follow your progress regardless of the process you settle on.
Good luck!